Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Update on Microsaic's miniaturised technology

28th Mar 2022 07:30

RNS Number : 1555G
Microsaic Systems plc
28 March 2022
 

Reach

 

28 March 2022

 

Microsaic Systems plc

("Microsaic" or the "Company")

Microsaic miniaturised technology in first UK deployment of COVID-19 sewage sentinel detection system

 

Microsaic Systems plc (AIM: MSYS), the developer of micro-engineering chip-based mass spectrometry equipment, is pleased to note the update by DeepVerge plc (AIM: DVRG) ("DeepVerge") provided today regarding the first UK deployment of their Microtox®PD pathogen detection system.

 

While there are no new orders for Microsaic at this stage, Microsaic and DeepVerge have continued to work closely together to develop further iterations of the Microtox®PD units and on potential upgrades to the existing Modern Water equipment in miniaturised form.

 

Gerry Brandon, Executive Chairman of Microsaic commented:

 

"These successful installations once again exemplify the close working partnership between DeepVerge and Microsaic, and our aligned approach to the application of miniaturised but powerful detection technologies in the environmental sector."

 

Enquiries:

 

 

Microsaic Systems plc

Gerry Brandon Chairman

 

+44 (0)734 0055 648

Singer Capital Markets(Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

 

 

About Microsaic

Microsaic develops and commercialises micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow, or in frontline environmental monitoring

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKOBPKBKBANB

Related Shares:

Microsaic
FTSE 100 Latest
Value8,809.74
Change53.53